These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 19303366)

  • 1. Dynamics of T cell activation accompanying CD4 recovery in antiretroviral treated HIV-infected Ugandan children.
    Ruel T; Ssewanyana I; Achan J; Gasasira A; Kamya MR; Kekitiinwa A; Wong JK; Cao H; Havlir D; Charlebois ED
    Clin Immunol; 2009 Jun; 131(3):410-4. PubMed ID: 19303366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of CD8+ T-cell activation on CD4+ T-cell recovery and mortality in HIV-infected Ugandans initiating antiretroviral therapy.
    Hunt PW; Cao HL; Muzoora C; Ssewanyana I; Bennett J; Emenyonu N; Kembabazi A; Neilands TB; Bangsberg DR; Deeks SG; Martin JN
    AIDS; 2011 Nov; 25(17):2123-31. PubMed ID: 21881481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of extended-release niacin on immune activation and neurocognition in HIV-infected patients treated with antiretroviral therapy - CTN PT006: study protocol for a randomized controlled trial.
    Lebouché B; Jenabian MA; Singer J; Graziani GM; Engler K; Trottier B; Thomas R; Brouillette MJ; Routy JP
    Trials; 2014 Oct; 15():390. PubMed ID: 25293882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of CD8 T cells normalizes and correlates with the level of infectious provirus in tonsils during highly active antiretroviral therapy in early HIV-1 infection.
    Dyrhol-Riise AM; Voltersvik P; Olofsson J; Asjö B
    AIDS; 1999 Dec; 13(17):2365-76. PubMed ID: 10597778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Older HIV-infected patients on antiretroviral therapy have B-cell expansion and attenuated CD4 cell increases with immune activation reduction.
    Kalayjian RC; Spritzler J; Matining RM; Fiscus SA; Gross BH; Francis IR; Pollard RB; Lederman MM; Landay A
    AIDS; 2013 Jun; 27(10):1563-71. PubMed ID: 24047762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of in vitro stimulation with lipopolysaccharide on T-cell activation in HIV-infected antiretroviral-treated patients.
    Tincati C; Bellistrì GM; Ancona G; Merlini E; d'Arminio Monforte A; Marchetti G
    Clin Dev Immunol; 2012; 2012():935425. PubMed ID: 22400042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD8+ T-cell activation in HIV-1-infected patients experiencing transient low-level viremia during antiretroviral therapy.
    Taiwo B; Hunt PW; Gandhi RT; Ellingson A; McKenna M; Jacobson JM; Gripshover B; Bosch RJ
    J Acquir Immune Defic Syndr; 2013 May; 63(1):101-4. PubMed ID: 23392463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.
    Zaccarelli-Filho CA; Ono E; Machado DM; Brunialti M; Succi RC; Salomão R; Kallás EG; de Moraes-Pinto MI
    Cytometry B Clin Cytom; 2007 Jan; 72(1):14-21. PubMed ID: 17041945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dominant enrichment of phenotypically activated CD38(+) HLA-DR(+) CD8(+) T cells, rather than CD38(+) HLA-DR(+) CD4(+) T cells, in HIV/HCV coinfected patients on antiretroviral therapy.
    d'Ettorre G; Ceccarelli G; Serafino S; Giustini N; Cavallari EN; Bianchi L; Pavone P; Bellelli V; Turriziani O; Antonelli G; Stroffolini T; Vullo V
    J Med Virol; 2016 Aug; 88(8):1347-56. PubMed ID: 26765625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4+ and CD8+ T cell activation are associated with HIV DNA in resting CD4+ T cells.
    Cockerham LR; Siliciano JD; Sinclair E; O'Doherty U; Palmer S; Yukl SA; Strain MC; Chomont N; Hecht FM; Siliciano RF; Richman DD; Deeks SG
    PLoS One; 2014; 9(10):e110731. PubMed ID: 25340755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-cell activation and neurodevelopmental outcomes in perinatally HIV-infected children.
    Kapetanovic S; Aaron L; Montepiedra G; Burchett SK; Kovacs A
    AIDS; 2012 May; 26(8):959-69. PubMed ID: 22382148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamics of CD8 T-cell activation after discontinuation of HIV treatment intensification.
    Massanella M; Esteve A; Buzón MJ; Llibre JM; Puertas MC; Gatell JM; Domingo P; Stevenson M; Clotet B; Martinez-Picado J; Blanco J;
    J Acquir Immune Defic Syndr; 2013 Jun; 63(2):152-60. PubMed ID: 23392458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naïve and memory CD4+ T cells and T cell activation markers in HIV-1 infected children on HAART.
    Resino S; Navarro J; Bellón JM; Gurbindo D; León JA; Muñoz-Fernández MA
    Clin Exp Immunol; 2001 Aug; 125(2):266-73. PubMed ID: 11529919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired T-cell proliferation among HAART-treated adults with suboptimal CD4 recovery in an African cohort.
    Nakanjako D; Ssewanyana I; Nabatanzi R; Kiragga A; Kamya MR; Cao H; Mayanja-Kizza H
    BMC Immunol; 2013 Jun; 14():26. PubMed ID: 23786370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1-specific cytolytic T-lymphocyte activity correlates with lower viral load, higher CD4 count, and CD8+CD38-DR- phenotype: comparison of statistical methods for measurement.
    Lubaki NM; Shepherd ME; Brookmeyer RS; Hon H; Quinn TC; Kashamuka M; Johnson M; Gottle R; Devers J; Lederman HM; Bollinger RC
    J Acquir Immune Defic Syndr; 1999 Sep; 22(1):19-30. PubMed ID: 10534143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Further evidence that the expression of CD38 and HLA-DR(+) in CD8(+) lymphocytes does not correlate to disease progression in HIV-1 vertically infected children.
    Romeiro JR; Pinto JA; Silva ML; Eloi-Santos SM
    J Int Assoc Physicians AIDS Care (Chic); 2012; 11(3):164-8. PubMed ID: 21976139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The correlation between HLA-DR or CD38 expression in CD8(+)T cells and CD4(+)T cells count in treatment-naive HIV/AIDS patients].
    Xie J; Qiu Z; Han Y; Li Y; Song X; Li T
    Zhonghua Nei Ke Za Zhi; 2016 Jan; 55(1):36-9. PubMed ID: 26796651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential upregulation of CD38 on different T-cell subsets may influence the ability to reconstitute CD4+ T cells under successful highly active antiretroviral therapy.
    Benito JM; López M; Lozano S; Ballesteros C; Martinez P; González-Lahoz J; Soriano V
    J Acquir Immune Defic Syndr; 2005 Apr; 38(4):373-81. PubMed ID: 15764953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. During HIV infection, CD4+ CD38+ T-cells are the predominant circulating CD4+ subset whose HLA-DR positivity increases with disease progression and whose V beta repertoire is similar to that of CD4+ CD38- T-cells.
    Ramzaoui S; Jouen-Beades F; Gilbert D; Borsa-Lebas F; Michel Y; Humbert G; Tron F
    Clin Immunol Immunopathol; 1995 Oct; 77(1):33-41. PubMed ID: 7554481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T-cell activation, both pre- and post-HAART levels, correlates with carotid artery stiffness over 6.5 years among HIV-infected women in the WIHS.
    Karim R; Mack WJ; Kono N; Tien PC; Anastos K; Lazar J; Young M; Desai S; Golub ET; Kaplan RC; Hodis HN; Kovacs A
    J Acquir Immune Defic Syndr; 2014 Nov; 67(3):349-56. PubMed ID: 25314253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.